AT
Aminex Therapeutics, Inc.
SEC filingBiotechnology · Kenmore, WA
Amount raised$15.1Msold at filing
Total offering$30M$14.9M still open
Investors in the raise162count reported to the SEC
FiledDec 5, 2025first sale Oct 25, 2022
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Deyaa AdibDirector
James SkaggsDirector
Mark BurnsExecutive Officer, Director
Jeffrey MillerDirector
David MeeksDirector
Don DyerDirector
Executive officers, directors and promoters as listed on the Form D.